ResearcherLanzhou University Second HospitalActive in the last 2 years
Xiao Li
Matched on ORCID iD 0000-0001-9504-605X; OpenAlex author ID A5114506653. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2024: 3 papers
Papers 3
- EREG silencing inhibits tumorigenesis via inactivating ERK/p38 MAPK pathway in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.bbadis.2024.167336↗
- Global burden of pancreatic cancer attributable to metabolic risks from 1990 to 2019, with projections of mortality to 2030. Co-author DOI 10.1186/s12889-024-17875-6↗
- Global, regional and national burden of pancreatic cancer and its attributable risk factors from 2019 to 2021, with projection to 2044. Co-author DOI 10.3389/fonc.2024.1521788↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Wenkai Jiang · 2 shared papers, 2024 · strength 0.56
- Paper Global burden of pancreatic cancer attributable to metabolic risks from 1990 to 2019, with projections of mortality to … DOI 10.1186/s12889-024-17875-6↗
- Paper Global, regional and national burden of pancreatic cancer and its attributable risk factors from 2019 to 2021, with pro… DOI 10.3389/fonc.2024.1521788↗
- Shaozhen Rui · 1 shared paper, 2024 · strength 0.28
- Wence Zhou · 1 shared paper, 2024 · strength 0.28
- Ru He · 1 shared paper, 2024 · strength 0.28
- Fuyuan Liu · 1 shared paper, 2024 · strength 0.21
- Juzheng Yuan · 1 shared paper, 2024 · strength 0.21
- Shuqiang Yue · 1 shared paper, 2024 · strength 0.21
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.